McColl M, Tait R C, Walker I D, Perry D J, McCall F, Conkie J A
Department of Haematology, Southern General Hospital, Glasgow, UK.
Blood Coagul Fibrinolysis. 1996 Oct;7(7):689-94. doi: 10.1097/00001721-199610000-00005.
We have previously identified a group of blood donors with inherited deficiencies of either antithrombin (AT) or protein C who appear to have a relatively low thrombosis rate. In the 5 years that have elapsed since initial identification of these individuals, resistance to activated protein C (APC resistance), which is associated with the factor V Leiden gene mutation, has emerged as an important and highly prevalent inherited thrombophilic risk factor. We have followed 28 donors/relatives with deficiency of AT (median age 48 years, range 16-77) and 23 with deficiency of protein C (median age 44 years, range 15-79) over a period of 5 years. During the study period only one individual, who was previously symptomatic, has suffered a thrombotic event which occurred spontaneously whilst on warfarin. We have now excluded coinheritance of APC resistance due to the factor V Leiden mutation in our cohort. Our findings demonstrate that individuals with single inherited thrombophilic defects are not uncommon and are frequently asymptomatic. The absence of the factor V Leiden mutation may in part explain the low thrombosis rate observed, and lends support to the hypothesis that multiple thrombophilic defects may be necessary for the development of thrombosis.
我们之前已识别出一组抗凝血酶(AT)或蛋白C遗传性缺陷的献血者,他们的血栓形成率似乎相对较低。自最初识别出这些个体后的5年里,与因子V莱顿基因突变相关的活化蛋白C抵抗(APC抵抗)已成为一种重要且高度普遍的遗传性血栓形成风险因素。我们对28名AT缺乏的献血者/亲属(中位年龄48岁,范围16 - 77岁)和23名蛋白C缺乏的献血者/亲属(中位年龄44岁,范围15 - 79岁)进行了为期5年的随访。在研究期间,只有一名既往有症状的个体在服用华法林时发生了自发性血栓形成事件。我们现已排除了我们队列中因因子V莱顿突变导致的APC抵抗的共同遗传情况。我们的研究结果表明,具有单一遗传性血栓形成缺陷的个体并不罕见,且通常无症状。因子V莱顿突变的缺失可能部分解释了所观察到的低血栓形成率,并支持了血栓形成可能需要多种血栓形成缺陷这一假说。